Ryan Govender
Chief Executive Officer en TREATT PLC .
Fortuna: 719 $ al 31/03/2024
Perfil
Ryan Govender is currently the Chief Executive Officer, Secretary & Director at Treatt Plc.
He previously worked as the Chief Financial Officer at SPI Pharma, Inc.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 20/06/2023 | 973 ( 0.00% ) | 574 $ | 31/03/2024 | |
TREATT PLC
0.00% | 14/03/2024 | 27 ( 0.00% ) | 145 $ | 31/03/2024 |
Cargos activos de Ryan Govender
| Empresas | Cargo | Inicio |
|---|---|---|
| TREATT PLC | Chief Executive Officer | 01/01/2024 |
Antiguos cargos conocidos de Ryan Govender.
| Empresas | Cargo | Fin |
|---|---|---|
SPI Pharma, Inc.
 SPI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of The Garfield Weston Foundation, SPI Pharma, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in Wilmington, DE. The CEO of the company is Scott Thomson. | Director of Finance/CFO | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| TREATT PLC | Process Industries |
| Empresas privadas | 1 |
|---|---|
SPI Pharma, Inc.
SPI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of The Garfield Weston Foundation, SPI Pharma, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in Wilmington, DE. The CEO of the company is Scott Thomson. | Health Technology |
- Bolsa de valores
- Insiders
- Ryan Govender
